Get the Stockscreener App
2.30
2.13%
-0.05
Tango Therapeutics Inc Stock (TNGX) Forecast
The Tango Therapeutics Inc (TNGX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.125, representing a -51.09% decrease from the current price of $2.30. The highest analyst price target is $1.5966, and the lowest is $0.6534.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TNGX Price Target
Average 1.7974
(-21.85% Downside)
Is Tango Therapeutics Inc (TNGX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.58 | Neutral |
| STOCH(9,6) | 8.9855 | Buy |
| STOCHRSI(14) | 3.8653 | Buy |
| MACD(12,26) | -0.2063 | Sell |
| ADX(14) | 19.10 | Neutral |
| William %R | -94.07 | Buy |
| CCI(14) | -66.56 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.421
Sell
|
2.4738
Sell
|
| MA20 |
2.7425
Sell
|
2.6411
Sell
|
| MA50 |
2.9075
Sell
|
3.099
Sell
|
| MA100 |
4.0013
Sell
|
4.138
Sell
|
| MA200 |
6.47
Sell
|
5.6853
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TNGX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on TNGX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.58 indicates that TNGX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 8.9855 indicates that TNGX is oversold. This indicates that TNGX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.8653 indicates that TNGX is oversold. This suggests that TNGX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.1 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -66.56 indicates that TNGX is still oversold but not to an extreme extent.
Long-term TNGX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tango Therapeutics Inc financial reports and earnings history, Tango Therapeutics Inc (TNGX) stock could reach $5.6541 by 2030, $26.42 by 2040 and $36.94 by 2050. See the projected annual prices until 2050 of the Tango Therapeutics Inc stock below:
- Tango Therapeutics Inc (TNGX) is expected to reach an average price of $14.32 in 2035, with a high prediction of $13.97 and a low estimate of $13.69. This indicates an $522.39% rise from the last recorded price of $2.30.
- Tango Therapeutics Inc (TNGX) stock is projected to chart a bullish course in 2040, with an average price target of $26.63, representing an $1,058% surge from its current level. The forecast ranges from a conservative $26.55 to a sky-high $26.42.
- Our analysts predict Tango Therapeutics Inc (TNGX) to jump 526.31% by 2045, soaring from $15.17 to an average price of $14.41, potentially reaching $15.90. While $15.17 is the low estimate, the potential upside is significant.
- Tango Therapeutics Inc (TNGX) stock is expected to climb by 2050, reaching an average of $36.95, a $1,507% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.94 and $36.88, respectively, highlighting the market's uncertainty.
Tango Therapeutics Inc Stock (TNGX) Year by Year Forecast
Tango Therapeutics Inc Stock (TNGX) Price Forecast for 2025
Tango Therapeutics Inc Stock (TNGX) is expected to reach an average price of $1.7974 in 2025, with a high prediction of $3.5801 and a low estimate of $0.0146. This indicates an -21.85% fall from the last recorded price of $2.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $0.8978 | $0.6534 | $1.5966 | -60.96% |
| April, 2025 | $1.2452 | $0.8093 | $0.7502 | -45.86% |
| May, 2025 | $0.9811 | $0.5296 | $0.7817 | -57.34% |
| June, 2025 | $1.687 | $1.2041 | $1.237 | -26.65% |
| July, 2025 | $2.1556 | $0.2383 | $2.3956 | -6.28% |
| August, 2025 | $2.7397 | $1.7641 | $3.4822 | +19.12% |
| September, 2025 | $2.9938 | $1.9953 | $3.4882 | +30.17% |
| October, 2025 | $2.9164 | $2.1279 | $3.2522 | +26.80% |
| November, 2025 | $1.8205 | $1.2805 | $3.5801 | -20.85% |
| December, 2025 | $0.5432 | $0.0146 | $2.4291 | -76.38% |
Tango Therapeutics Inc Stock (TNGX) Price Forecast for 2026
The predicted value for Tango Therapeutics Inc (TNGX) in 2026 is set at an average of $4.6516. Estimates vary from a peak of $8.9915 to a trough of $0.3117, indicating an +102.24% surge from the present price of $2.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.4427 | $0.3117 | $0.8717 | -80.75% |
| February, 2026 | $0.9286 | $0.3872 | $0.4142 | -59.62% |
| March, 2026 | $0.7445 | $0.9435 | $0.9816 | -67.63% |
| April, 2026 | $0.8619 | $1.0919 | $1.4075 | -62.53% |
| May, 2026 | $0.8678 | $1.1478 | $0.9013 | -62.27% |
| June, 2026 | $0.8237 | $1.1278 | $0.8622 | -64.19% |
| July, 2026 | $3.0289 | $0.8452 | $5.1848 | +31.69% |
| August, 2026 | $7.203 | $2.6474 | $7.557 | +213.17% |
| September, 2026 | $4.4356 | $1.1301 | $8.9915 | +92.85% |
| October, 2026 | $3.6397 | $2.9712 | $5.2127 | +58.25% |
| November, 2026 | $6.8238 | $3.5183 | $6.9638 | +196.69% |
| December, 2026 | $7.2065 | $5.0994 | $7.9665 | +213.32% |
Tango Therapeutics Inc Stock (TNGX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tango Therapeutics Inc (TNGX) is $4.6731, with a high forecast of $9.322 and a low forecast of $0.0241. This indicates an +103.18% increase from the last price of $2.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.7606 | $7.065 | $9.322 | +280.89% |
| February, 2027 | $7.8647 | $7.0476 | $9.1691 | +241.94% |
| March, 2027 | $3.8973 | $3.5673 | $8.3032 | +69.45% |
| April, 2027 | $4.2914 | $3.4843 | $4.6114 | +86.58% |
| May, 2027 | $0.6641 | $0.0241 | $4.4149 | -71.13% |
| June, 2027 | $0.4794 | $0.0694 | $2.5382 | -79.16% |
| July, 2027 | $1.7824 | $0.0564 | $2.0835 | -22.50% |
| August, 2027 | $1.0642 | $1.4842 | $1.0055 | -53.73% |
| September, 2027 | $3.879 | $1.9172 | $2.789 | +68.65% |
| October, 2027 | $2.3408 | $3.1478 | $3.2119 | +1.77% |
| November, 2027 | $3.2226 | $2.8367 | $2.4726 | +40.11% |
| December, 2027 | $3.7173 | $3.6055 | $3.6744 | +61.62% |
Tango Therapeutics Inc Stock (TNGX) Price Forecast for 2028
In 2028, Tango Therapeutics Inc (TNGX) is projected to reach an average price of $4.4008, with a high projection of $6.647 and a low estimate of $2.1547. This indicates an +91.34% rise from the last price of $2.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.0891 | $4.2203 | $3.5762 | +121.27% |
| February, 2028 | $4.3509 | $4.8309 | $5.34 | +89.17% |
| March, 2028 | $6.3257 | $4.6439 | $5.9398 | +175.03% |
| April, 2028 | $6.5475 | $6.2016 | $6.0186 | +184.67% |
| May, 2028 | $6.2422 | $5.8093 | $6.0984 | +171.40% |
| June, 2028 | $6.874 | $6.4281 | $6.424 | +198.87% |
| July, 2028 | $5.0558 | $6.4458 | $6.647 | +119.82% |
| August, 2028 | $2.2806 | $2.1547 | $2.6988 | -0.84% |
| September, 2028 | $1.9524 | $2.4835 | $2.1994 | -15.11% |
| October, 2028 | $2.4942 | $2.4212 | $1.8592 | +8.44% |
| November, 2028 | $2.9589 | $2.3801 | $2.9389 | +28.65% |
| December, 2028 | $4.5807 | $3.3119 | $3.6907 | +99.16% |
Tango Therapeutics Inc Stock (TNGX) Price Forecast for 2029
The 2029 price forecast for Tango Therapeutics Inc Stock (TNGX) is $2.9431 on average, with a high prediction of $5.835 and a low estimate of $0.0513. This represents an +27.96% increase from the previous price of $2.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.0555 | $4.3566 | $4.7075 | +119.80% |
| February, 2029 | $5.4673 | $4.9443 | $5.0084 | +137.71% |
| March, 2029 | $5.2091 | $5.4081 | $5.4832 | +126.48% |
| April, 2029 | $5.4409 | $5.6409 | $5.835 | +136.56% |
| May, 2029 | $5.1656 | $5.4456 | $5.2177 | +124.59% |
| June, 2029 | $5.0474 | $5.3524 | $5.1045 | +119.45% |
| July, 2029 | $1.8092 | $1.6633 | $0.9796 | -21.34% |
| August, 2029 | $3.146 | $0.199 | $3.50 | +36.78% |
| September, 2029 | $0.0442 | $1.1558 | $4.9531 | -98.08% |
| October, 2029 | $0.2505 | $0.0513 | $1.2854 | -89.11% |
| November, 2029 | $3.0077 | $0.1794 | $3.1477 | +30.77% |
| December, 2029 | $3.4559 | $1.3388 | $4.0259 | +50.26% |
Tango Therapeutics Inc Stock (TNGX) Price Forecast for 2030
Tango Therapeutics Inc Stock (TNGX) is expected to reach an average price of $4.7001 in 2030, with a high forecast of $9.3616 and a low forecast of $0.0387. This signifies an +104.35% surge from the last price of $2.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1111 | $2.2679 | $5.6541 | +122.22% |
| February, 2030 | $4.2893 | $3.4352 | $5.5382 | +86.49% |
| March, 2030 | $0.9375 | $0.3175 | $4.7464 | -59.24% |
| April, 2030 | $0.5857 | $0.0387 | $1.1746 | -74.53% |
| May, 2030 | $5.5788 | $0.4198 | $5.3288 | +142.56% |
| June, 2030 | $5.6215 | $5.5477 | $4.9865 | +144.42% |
| July, 2030 | $7.8587 | $6.0754 | $7.6687 | +241.68% |
| August, 2030 | $7.0664 | $7.4864 | $7.0632 | +207.23% |
| September, 2030 | $9.4841 | $7.9008 | $8.5641 | +312.35% |
| October, 2030 | $8.1762 | $8.9962 | $9.1029 | +255.49% |
| November, 2030 | $8.9839 | $8.635 | $8.2339 | +290.60% |
| December, 2030 | $9.5716 | $9.3483 | $9.3616 | +316.16% |
0.53%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):